Keflex

   
Google
 
Web NewDrugInformation.com

Keflex


Drug - Keflex
The trade name of the product as shown on the labeling.

Dosage - FOR SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cephalexin
Multiple ingredients are in alphabetical order.

Strength - EQ 125MG BASE/5ML
The potency of the active ingredient(s), Cephalexin. May repeat for multiple part products.

Applicant - ADVANCIS PHARM
The firm name holding legal responsibility for Keflex. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050406
The FDA assigned number to Keflex. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Keflex. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Keflex was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Keflex. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Keflex is in. Format is RX, OTC, DISCN.

Applicant Full Name - Advancis Pharmaceutical Corp
The full name of the firm holding legal responsibility for the new application of Keflex.

Keflex